Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.44 USD | +1.90% |
|
-1.20% | +54.91% |
12:00am | Enliven Therapeutics, Inc.(NasdaqGS:ELVN) added to S&P Pharmaceuticals Select Industry Index | CI |
06-11 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ENLIVEN THERAPEUTICS, INC. | Bio Therapeutic Drugs | +1.90% | -1.20% | +54.91% | +1.71% | - | 1.01B | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- ELVN Stock
- Charts Enliven Therapeutics, Inc.
- Comparison Chart